메뉴 건너뛰기




Volumn 40, Issue 4, 2007, Pages 278-284

Adverse drug reaction surveillance system in Korea

Author keywords

Adverse drug reaction reporting systems; Data mining; Drug toxicity; Postmarketing; Product surveillance

Indexed keywords

DRUG SURVEILLANCE PROGRAM; HUMAN; INFORMATION SYSTEM; KOREA; MEDICAL INFORMATICS; ORGANIZATION AND MANAGEMENT; POSTMARKETING SURVEILLANCE; REVIEW;

EID: 34548563976     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.2007.40.4.278     Document Type: Article
Times cited : (24)

References (9)
  • 1
    • 0032522873 scopus 로고    scopus 로고
    • Incidence of adverse drug reactions in hospitalized patients: A meta- analysis of prospective studies
    • DOI 10.1001/jama.279.15.1200
    • Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200-1205 (Pubitemid 28193431)
    • (1998) Journal of the American Medical Association , vol.279 , Issue.15 , pp. 1200-1205
    • Lazarou, J.1    Pomeranz, B.H.2    Corey, P.N.3
  • 2
  • 4
    • 84887245433 scopus 로고    scopus 로고
    • Activation of drug adverse event spontaneous reporting
    • (Korean)
    • Park BJ. Activation of drug adverse event spontaneous reporting. J Korean Med Assoc 2002; 45(11): 1274-1279 (Korean)
    • (2002) J Korean Med Assoc , vol.45 , Issue.11 , pp. 1274-1279
    • Park, B.J.1
  • 5
    • 0032444841 scopus 로고    scopus 로고
    • Re-examination system for new drugs in Korea
    • (Korean)
    • Park BJ. Re-examination system for new drugs in Korea. J Korean Soc Clin Pharmacol 1998; 6(1): 3-15 (Korean)
    • (1998) J Korean Soc Clin Pharmacol , vol.6 , Issue.1 , pp. 3-15
    • Park, B.J.1
  • 6
    • 0030497852 scopus 로고    scopus 로고
    • Regulatory pharmacovigilance in the United Kingdom: Current principles and practice
    • DOI 10.1002/(SICI)1099-1557(199611)5:6 <363::AID-PDS249>3.0.CO;2-7
    • Waller PC, Coulson RA, Wood SM. Regulatory pharmacovigilance in the United Kingdom: Current principles and practice. Pharmacoepidemiol Drug Saf 1996; 5(6): 363-375 (Pubitemid 27062318)
    • (1996) Pharmacoepidemiology and Drug Safety , vol.5 , Issue.6 , pp. 363-375
    • Waller, P.C.1    Coulson, R.A.2    Wood, S.M.3
  • 7
    • 0037275431 scopus 로고    scopus 로고
    • A model for the future conduct of pharmacovigilance
    • DOI 10.1002/pds.773
    • Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf 2003; 12(1): 17-29 (Pubitemid 36192946)
    • (2003) Pharmacoepidemiology and Drug Safety , vol.12 , Issue.1 , pp. 17-29
    • Waller, P.C.1    Evans, S.J.W.2
  • 8
    • 24344486667 scopus 로고    scopus 로고
    • Data mining in pharmacovigilance: The need for a balanced perspective
    • DOI 10.2165/00002018-200528100-00001
    • Hauben M, Patadia V, Gerrits C, Walsh L, Reich L. Data mining in pharmacovigilance: The need for a balanced perspective. Drug Saf 2005; 28(10): 835-842 (Pubitemid 41428541)
    • (2005) Drug Safety , vol.28 , Issue.10 , pp. 835-842
    • Hauben, M.1    Patadia, V.2    Gerrits, C.3    Walsh, L.4    Reich, L.5
  • 9
    • 84887243177 scopus 로고    scopus 로고
    • Food and Drug Administration (FDA). Public Law 105-115 [cited 2007 Jun 15]
    • Food and Drug Administration (FDA). FDA Moderization Act of 1997. Public Law 105-115 [cited 2007 Jun 15]; Available from: URL:http: //www.fda.gov/cder/ guidance/105-115.htm
    • FDA Moderization Act of 1997


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.